We are live on ! Find out more
ZURA icon

Zura Bio

33 hedge funds and large institutions have $80.5M invested in Zura Bio in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

36% more capital invested

Capital invested by funds: $59M → $80.5M (+$21.4M)

8% less funds holding

Funds holding: 3633 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
33
Holders Change
-3
Holders Change %
-8.33%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
9
Reduced
3
Closed
6
Calls
$164K
Puts
Net Calls
+$164K
Net Calls Change
-$7K

ZURA Hedge Fund Activity: Q3 2022 in Review

33 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q3 2022, worth a combined $80.5M — up 36% from $59M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ZURA and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 9 added.

The largest buyer was Glazer Capital LLC, adding an estimated $2.99M. The largest seller was Basso Capital Management, exiting entirely with an estimated $1.94M sold.

  • 33 institutional investors held Zura Bio (ZURA) as of Q3 2022, down from 36 in Q2 2022.
  • Funds reported $80.5M of Zura Bio stock for Q3 2022, up 36% quarter-over-quarter.
  • 3 funds opened new Zura Bio positions in Q3 2022 and 6 closed out, a net change of -3 holders.
  • The largest Zura Bio buyer in Q3 2022 was Glazer Capital LLC, an estimated $2.99M added.
  • The largest Zura Bio seller in Q3 2022 was Basso Capital Management, an estimated $1.94M sold.

Based on aggregated 13F filings for Q3 2022.